IGF-1 and epidermal growth factor levels in follicular fluid of women undergoing controlled ovarian hyperstimulation using the multidose GnRH-antagonist protocol or the long GnRH-agonist protocol

被引:9
|
作者
Asimakopoulos, B.
Schoepper, B.
Dawson, A.
Caglar, G. S.
Vakalopoulos, I.
Al-Hasani, S.
Diedrich, K.
Nikolettos, N. [1 ]
机构
[1] Democritus Univ Thrace, Sch Med, Physiol Lab, Alexandroupolis 68100, Greece
[2] Univ Schleswig Holstein, Dept Obstet & Gynecol, Lubeck, Germany
关键词
IGF-I; EGF; follicular fluid; GnRH-antagonist; GnRH-agonist;
D O I
10.1007/BF03344118
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The intrafollicular levels of IGF-1 and epidermal growth factor (EGF) were studied in women undergoing controlled ovarian hyperstimulation using the multiclose GnRH-antagonist protocol or the long agonist protocol, in an attempt to elucidate whether GnRH-antagonists affect the levels of the two growth factors. The follicular fluid concentration of IGF-1, EGF, estradiol and progesterone were detected in 68 women undergoing ovarian hyperstimulation for intracytoplasmic sperm injection (ICSI) cycles. There were no differences in intrafollicular concentrations of EGF and IGF-1 in the two studied groups. Additionally, we found no correlation between the intrafollicular levels of IGF-1 or EGF and the ICS1 outcome. The intrafollicular levels of IGF-1 were positively correlated with those of progesterone. In conclusion, the intrafollicular levels of IGF-1 and EGF do not seem to be influenced by the stimulation protocol. The intrafollicular levels of both growth factors can not serve as prognostic markers for the ICS1 outcome.
引用
收藏
页码:RC5 / RC8
页数:4
相关论文
共 36 条
  • [1] IGF-I and epidermal growth factor levels in follicular fluid of women undergoing controlled ovarian hyperstimulation using the multidose GnRH-antagonist protocol or the long GnRH-agonist protocol
    B. Asimakopoulos
    B. Schöpper
    A. Dawson
    G. S. Caglar
    I. Vakalopoulos
    S. Al-Hasani
    K. Diedrich
    N. Nikolettos
    [J]. Journal of Endocrinological Investigation, 2006, 29 : RC5 - RC8
  • [2] GnRH-Agonist Ovulation Trigger in Patients Undergoing Controlled Ovarian Hyperstimulation for IVF with Stop GnRH-Agonist Combined with Multidose GnRH-Antagonist Protocol
    Orvieto, Raoul
    Nahum, Ravit
    Zohav, Efraim
    Liberty, Gad
    Anteby, Eyal Y.
    Meltcer, Simion
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2021, 86 (05) : 427 - 431
  • [3] GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol
    Orvieto, Raoul
    Nahum, Ravit
    Zohav, Efraim
    Liberty, Gad
    Anteby, Eyal Y.
    Meltcer, Simion
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (01) : 51 - 53
  • [4] Single dose GnRH-antagonist cetrorelix vs. long protocol GnRH-agonist in patients undergoing controlled ovarian hyperstimulation for IVF.
    Hamori, M
    Antoni, K
    [J]. FERTILITY AND STERILITY, 2001, 76 (03) : S147 - S148
  • [5] Similar outcome for cryopreserved embryo transfer following GnRH-antagonist/GnRH-agonist, GnRH-antagonist/HCG or long protocol ovarian stimulation
    Eldar-Geva, Talia
    Zylber-Haran, Edit
    Babayof, Rachel
    Halevy-Shalem, Tamar
    Ben-Chetrit, Avraharn
    Tsafrir, Avi
    Varshaver, Irit
    Brooks, Baruch
    Margalioth, Ehud J.
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2007, 14 (02) : 148 - 154
  • [6] Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With "Genuine" Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF
    Orvieto, Raoul
    Kirshenbaum, Michal
    Galiano, Valentina
    Elkan-Miller, Tal
    Zilberberg, Eran
    Haas, Jigal
    Nahum, Ravit
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [7] Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosis-associated infertility: GnRH-agonist versus GnRH-antagonist
    Kolanska, K.
    Cohen, J.
    Bendifallah, S.
    Selleret, L.
    Antoine, J. -M.
    Chabbert-Buffet, N.
    Darai, E.
    d'Argent, E. -M.
    [J]. JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2017, 46 (09) : 681 - 686
  • [8] Economic evaluation of GnRH-agonist long protocol and GnRH-antagonist protocol in IVT/ICSI among the Chinese population: using pharmacoeconomic models
    Si, Yuxin
    Chen, Chunlan
    Tang, Yalan
    Zhang, Min
    Tang, Junying
    Pu, Kexue
    [J]. BMJ OPEN, 2024, 14 (08):
  • [9] Controlled ovarian hyperstimulation using multi-dose gonadotropin-releasing hormone (GnRH) antagonist results in less systemic inflammation than the GnRH-agonist long protocol
    Orvieto, Raoul
    Volodarsky, Michael
    Hod, Eduard
    Homburg, Roy
    Rabinson, Jacob
    Zohav, Efraim
    Anteby, Eyal Y.
    Meltcer, Simion
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (08) : 494 - 496
  • [10] Pregnancy rates and risk of ovarian hyperstimulation syndrome (OHSS) in a fixed GnRH-antagonist versus GnRH-agonist protocol: randomized controlled trial including 1099 first IVF/ICSI cycles
    Toftager, M.
    Bogstad, J.
    Lossl, K.
    Praetorius, L.
    Zedeler, A.
    Bryndorf, T.
    Nilas, L.
    Pinborg, A.
    [J]. HUMAN REPRODUCTION, 2015, 30 : 94 - 95